A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : TTR

Search Conditions:
Search Keyword : TTR
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: TTR
Appearance Frequency: 2772 time(s)
Long forms: 192

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
transthyretin
(1753 times)
Biochemistry
(405 times)
FAP (327 times)
RBP (130 times)
CSF (72 times)
1984 Immunocytochemical studies on the localization of plasma and of cellular retinol-binding proteins and of transthyretin (prealbumin) in rat liver and kidney.
therapeutic range
(385 times)
Vascular Diseases
(91 times)
INR (151 times)
AF (114 times)
VKA (47 times)
2006 Worldwide management of oral anticoagulant therapy: the ISAM study.
time to recurrence
(197 times)
Neoplasms
(118 times)
OS (128 times)
HCC (58 times)
HR (34 times)
1993 Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients.
time to relapse
(43 times)
Neoplasms
(24 times)
OS (17 times)
NSCLC (6 times)
AML (4 times)
1989 LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
time to response
(28 times)
Neoplasms
(16 times)
DOR (12 times)
ORR (11 times)
PFS (9 times)
1981 Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatment.
wild-type transthyretin
(20 times)
Biochemistry
(4 times)
SSA (7 times)
FAP (3 times)
HFpEF (2 times)
1996 Structure of the Val122Ile variant transthyretin - a cardiomyopathic mutant.
time to tumor recurrence
(17 times)
Neoplasms
(9 times)
OS (8 times)
HR (6 times)
CI (4 times)
2008 Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
time to results
(14 times)
Microbiology
(6 times)
DST (2 times)
LOD (2 times)
aM (1 time)
2002 Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System.
time-in-therapeutic range
(12 times)
Vascular Diseases
(9 times)
AF (3 times)
INR (2 times)
ACR (1 time)
2003 Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range.
10  tracer-to-tracee ratio
(12 times)
Physiology
(4 times)
EGP (2 times)
GC/MS (2 times)
IVGTT (2 times)
1997 Measurement of very low stable isotope enrichments by gas chromatography/mass spectrometry: application to measurement of muscle protein synthesis.
11  thermotolerance ratio
(11 times)
Neoplasms
(6 times)
CHM (2 times)
PUR (2 times)
SUH (1 time)
1984 Heat sensitivity and thermotolerance in cells from five human melanoma xenografts.
12  transthyretin gene
(9 times)
Neurology
(2 times)
AAO (1 time)
BCVA (1 time)
CI (1 time)
2009 Transthyretin gene (TTR) intron 1 elucidates crocodylian phylogenetic relationships.
13  type-token ratio
(8 times)
Speech-Language Pathology
(3 times)
MLUw (2 times)
BG (1 time)
BNT (1 time)
1981 Formal thought disorder, the type-token ratio and disturbed voluntary motor movement in schizophrenia.
14  anti-transthyretin
(7 times)
Neurology
(4 times)
AAV (1 time)
AD (1 time)
bGH (1 time)
1993 Immunoassay for transthyretin variants associated with amyloid neuropathy.
15  target therapeutic range
(7 times)
Vascular Diseases
(3 times)
AF (2 times)
INR (2 times)
OAT (1 time)
2003 Acenocoumarol therapy in pediatric patients.
16  tear turnover rate
(7 times)
Ophthalmology
(5 times)
ADDE (2 times)
EDE (2 times)
DE (1 time)
2001 An improved fluorophotometric method for tear turnover assessment.
17  time to recovery
(6 times)
Cardiology
(1 time)
HD (2 times)
AUCs (1 time)
BFR (1 time)
1997 The prediction of length of major depressive episodes: results from an epidemiological sample of female twins.
18  type transthyretin
(5 times)
Biochemistry
(2 times)
RBP4 (1 time)
SLE (1 time)
2008 Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture.
19  RBP-transthyretin
(4 times)
Biochemistry
(3 times)
RBP (3 times)
Ito (1 time)
mAbs (1 time)
1991 Regulation of retinol uptake and esterification in MCF-7 and HepG2 cells by exogenous fatty acids.
20  Tabtoxin resistance protein
(4 times)
Molecular Biology
(2 times)
AcCoA (2 times)
GNAT (1 time)
HATs (1 time)
2001 Crystallization and preliminary X-ray crystallographic analysis of native and selenomethionyl recombinant tabtoxin-resistance protein complexed with acetyl-coenzyme A.
21  target range
(4 times)
Vascular Diseases
(2 times)
AF (2 times)
INR (2 times)
AC (1 time)
2000 Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management.
22  time to disease recurrence
(4 times)
Neoplasms
(4 times)
OS (2 times)
EHC (1 time)
GBC (1 time)
2010 The prognostic value of tumor mitotic rate and other clinicopathologic factors in patients with locoregional recurrences of melanoma.
23  time to resolution
(4 times)
Neoplasms
(3 times)
AMC (1 time)
CT (1 time)
DB (1 time)
2014 Neighborhood factors associated with time to resolution following an abnormal breast or cervical cancer screening test.
24  transition temperature range
(4 times)
Orthodontics
(3 times)
DSC (2 times)
Af (1 time)
Ms (1 time)
1980 A clinical trial of alignment of teeth using a 0.019 inch thermal nitinol wire with a transition temperature range between 31 degrees C. and 45 degrees C.
25  translation regulatory
(4 times)
Chemistry
(1 time)
RBPs (3 times)
DSRBPs (1 time)
NF90 (1 time)
2007 Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs.
26  TBG, transthyretin
(3 times)
Neoplasms
(1 time)
TBG (2 times)
ACT (1 time)
AT (1 time)
1992 Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells.
27  tetrathionate reductase
(3 times)
Microbiology
(2 times)
TSO (2 times)
TSR (1 time)
1980 Thiosulfate Oxidation and Tetrathionate Reduction by Intact Cells of Marine Pseudomonad Strain 16B.
28  therapeutic International Normalized Ratio range
(3 times)
Vascular Diseases
(1 time)
ACTS (1 time)
AF (1 time)
RE-LY (1 time)
2010 Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
29  transcriptional termination region
(3 times)
Clinical Laboratory Techniques
(1 time)
CGIs (1 time)
DME-like (1 time)
nc (1 time)
2008 Genetic heterogeneity of the dnaK gene locus including transcription terminator region (TTR) in Campylobacter lari.
30  transthyretin-related
(3 times)
Biochemistry
(1 time)
AC (1 time)
AL (1 time)
CI (1 time)
2005 Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation.
31  Trauma Triage Rule
(3 times)
Emergency Medicine
(3 times)
--- 1992 Comparative performance of the Baxt Trauma Triage Rule.
32  true three-dimensional reconstruction
(3 times)
Diagnostic Imaging
(2 times)
ETTR (1 time)
TTCR (1 time)
1983 True Three-Dimensional Reconstruction (TTR) Application of Algorithm toward Full Utilization of Oblique Rays.
33  targeting transthyretin
(2 times)
Therapeutics
(1 time)
1,5-AmNS (1 time)
1,8-ANS (1 time)
siRNA (1 time)
2010 Identification of a novel ligand binding motif in the transthyretin channel.
34  tetrameric transthyretin
(2 times)
Chemistry
(1 time)
FAP (1 time)
SSA (1 time)
2005 Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.
35  TH transport protein transthyretin
(2 times)
Toxicology
(1 time)
Cl-PFAESs (1 time)
PFASs (1 time)
PFOS (1 time)
2016 Binding interactions of perfluoroalkyl substances with thyroid hormone transport proteins and potential toxicological implications.
36  thyroglossal tract remnant
(2 times)
Otolaryngology
(1 time)
--- 2008 Thyroglossal duct cyst: personal experience and literature review.
37  thyroxine transport protein transthyretin
(2 times)
Environmental Pollutants
(1 time)
--- 2005 Hydroxylated polychlorinated biphenyls (OH-PCBs): recent advances in wildlife contamination study.
38  tibiotarsal rotation
(2 times)
Veterinary Medicine
(2 times)
--- 1998 Factors on farms in eastern Australia associated with the development of tibiotarsal rotation in ostrich chicks.
39  time from initial diagnosis to relapse
(2 times)
Transplantation
(1 time)
ALC-R (1 time)
DLBCL (1 time)
IPI-R (1 time)
2008 Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation.
40  time to overall recurrence
(2 times)
Neoplasms
(2 times)
OS (1 time)
TTLiR (1 time)
TTM (1 time)
2008 Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.
41  time to repeat
(2 times)
Endocrinology
(1 time)
CBG (1 time)
TLA (1 time)
2017 Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia.
42  time to tumor response
(2 times)
Neoplasms
(1 time)
PFS (2 times)
CK (1 time)
CR (1 time)
2014 Sunitinib objective response in metastatic renal cell carcinoma: analysis of 1059 patients treated on clinical trials.
43  time-to-readmission
(2 times)
General Surgery
(2 times)
--- 2015 Time-to-readmission and Mortality After High-risk Surgery.
44  total thermal response
(2 times)
Neurology
(2 times)
DA (2 times)
GFAP (2 times)
CP (1 time)
1997 Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response.
45  transient thermoreflectance
(2 times)
Biomedical Engineering
(2 times)
FDTR (1 time)
2008 Pulse accumulation, radial heat conduction, and anisotropic thermal conductivity in pump-probe transient thermoreflectance.
46  transporter transthyretin
(2 times)
Toxicology
(1 time)
CPs (1 time)
FT4 (1 time)
PBDE (1 time)
2002 Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects.
47  transthoracic resistance
(2 times)
Cardiology
(2 times)
TMR (1 time)
VF (1 time)
1981 Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure.
48  transthyretin precursor
(2 times)
Biochemistry
(1 time)
6-PDGH (1 time)
AAT (1 time)
Apo J (1 time)
2008 Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers.
49  transthyretin protein
(2 times)
Computational Biology
(1 time)
FAP (2 times)
BEI (1 time)
CBS (1 time)
2011 Retrospective Mapping of SAR Data for TTR Protein in Chemico-Biological Space Using Ligand Efficiency Indices as a Guide to Drug Discovery Strategies.
50  transthyretin-bound
(2 times)
Chemistry Techniques, Analytical
(1 time)
RBP (2 times)
holo (1 time)
1990 Use of free and transthyretin-bound retinol-binding protein in serum as tests of vitamin A status in humans: effect of high creatinine concentrations in serum.
51  transverse transmission/reflection
(2 times)
Ophthalmology
(2 times)
ARROW (1 time)
MIM (1 time)
2009 Attenuation and mode profile determination of leaky/lossy modes in multilayer planar waveguides by a coupling simulation method.
52  treatment required
(2 times)
Gastroenterology
(1 time)
CS (1 time)
FL (1 time)
LTB (1 time)
2016 The role of "watch and wait" in intestinal follicular lymphoma in rituximab era.
53  triceps tendon ruptures
(2 times)
Orthopedics
(1 time)
DKS (1 time)
2015 Functional outcomes and complications after surgical repair of triceps tendon rupture.
54  Tumour Tissue Repository
(2 times)
Preservation, Biological
(2 times)
BC (1 time)
GI (1 time)
PTC (1 time)
2013 Impact of a Permission to Contact (PTC) platform on biobank enrollment and efficiency.
55  fat-to-total fat ratio
(1 time)
Endocrine System Diseases
(1 time)
BMI (1 time)
LATR (1 time)
LM (1 time)
2016 Relationship of lean mass and obesity in Indian urban children and adolescents.
56  H2-treatment temperature
(1 time)
Biophysics
(1 time)
--- 2018 On the origin of high-temperature phenomena in Pt/Al2O3.
57  Met30-transthyretin
(1 time)
Genetics, Medical
(1 time)
FAP (1 time)
1998 A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.
58  mRNA--transthyretin
(1 time)
Biology
(1 time)
AAT (1 time)
AFP (1 time)
ALB (1 time)
2006 In vitro differentiation of mouse ES cells into hepatocytes with coagulation factors VIII and IX expression profiles.
59  N-terminal region of transthyretin
(1 time)
Biochemistry
(1 time)
RBP (1 time)
THs (1 time)
2011 Effect of the N-terminal sequence on the binding affinity of transthyretin for human retinol-binding protein.
60  re-treatment
(1 time)
Hematology
(1 time)
CLL (1 time)
CR (1 time)
FC (1 time)
2011 Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
61  T-tube repair
(1 time)
Diagnostic Imaging
(1 time)
BDIs (1 time)
CJ (1 time)
ERC (1 time)
2008 Iatrogenic biliary injury: 13,305 cholecystectomies experienced by a single surgical team over more than 13 years.
62  table-top autorefractor
(1 time)
Eye Diseases
(1 time)
CV (1 time)
Rmax (1 time)
SEV (1 time)
2014 Comparison of the Retinomax hand-held autorefractor versus table-top autorefractor and retinoscopy.
63  tafamidis to ameliorate transthyretin
(1 time)
Biochemistry
(1 time)
--- 2015 Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy).
64  tafamidis treatment on transthyretin
(1 time)
Neurology
(1 time)
AEs (1 time)
mBMI (1 time)
NIS-LL (1 time)
2016 Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
65  tailored telescopic reconstruction
(1 time)
Gastroenterology
(1 time)
cDDRs (1 time)
DDR (1 time)
LDLT (1 time)
2010 Tailored telescopic reconstruction of the bile duct in living donor liver transplantation.
66  Talent Thoracic Retrospective Registry
(1 time)
Cardiology
(1 time)
--- 2009 Emergency treatment of the thoracic aorta: results in 113 consecutive acute patients (the Talent Thoracic Retrospective Registry).
67  tandem tetranucleotide repeat
(1 time)
Genetics
(1 time)
CF (1 time)
CFTR (1 time)
2002 [Analysis of the spectra of mutations and polymorphic loci of cystic fibrosis transmembrane conductance regulator in the population of Bashkortostan].
68  Tangtong Recipe
(1 time)
Complementary Therapies
(1 time)
VSMCs (1 time)
2009 [Effect of tangtong recipe on the proliferation of cultured iliac arterial smooth muscle cells of diabetic rats in vitro].
69  target INR
(1 time)
Pharmacology
(1 time)
AF (1 time)
GP (1 time)
INR (1 time)
2016 Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management.
70  target international normalised ratio range
(1 time)
Medicine
(1 time)
AF (1 time)
VKAs (1 time)
VTE (1 time)
2014 Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review.
71  target tumour response
(1 time)
Radiology
(1 time)
GIST (1 time)
2005 Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI.
72  targeted therapy resistance
(1 time)
Neoplasms
(1 time)
CSCs (1 time)
TT (1 time)
2017 At the crossroads of cancer stem cells and targeted therapy resistance.
73  tarsal tunnel release
(1 time)
General Surgery
(1 time)
PNR (1 time)
SFI (1 time)
SSEP (1 time)
2007 Effect of early nerve release on the progression of neuropathy in diabetic rats.
74  taurultame-taurinamide ratio
(1 time)
Pharmacology
(1 time)
HPLC (1 time)
2007 Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.
75  taxa-time relationship
(1 time)
Medicine
(1 time)
CCA (1 time)
DO (1 time)
2014 Bacterial community dynamics and taxa-time relationships within two activated sludge bioreactors.
76  TBPA then was renamed transthyretin
(1 time)
Chemistry, Clinical
(1 time)
RBP (1 time)
TBPA (1 time)
2002 Transthyretin from discovery to now.
77  tectoridin
(1 time)
Drug Therapy
(1 time)
JSRVs (1 time)
RyR (1 time)
2000 Tectoridins modulate skeletal and cardiac muscle sarcoplasmic reticulum calcium-release channels.
78  Tectorigenin
(1 time)
Complementary Therapies
(1 time)
MRSA (1 time)
PGN (1 time)
TEM (1 time)
2014 The Antibacterial Assay of Tectorigenin with Detergents or ATPase Inhibitors against Methicillin-Resistant Staphylococcus aureus.
79  temperature rise
(1 time)
Anthropology
(1 time)
BD (1 time)
CIVD (1 time)
JP (1 time)
2016 Cold-induced vasodilation comparison between Bangladeshi and Japanese natives.
80  temperature transition range
(1 time)
Dentistry
(1 time)
--- 1979 55 Nitinol wire: force developed as a function of "elastic memory".
81  tendon ruptures
(1 time)
Orthopedics
(1 time)
QTR (1 time)
2018 Simultaneous Ipsilateral Quadriceps and Triceps Tendon Rupture in a Patient with End-Stage Renal Failure.
82  tendon tap response
(1 time)
Physical Medicine
(1 time)
DTR (1 time)
2013 Position-dependent, hyperexcitable patellar reflex dynamics in chronic stroke.
83  tension to rupture
(1 time)
Nutritional Sciences
(1 time)
DXR (1 time)
ECG (1 time)
TSNIIA-SS (1 time)
2009 Tanshinone IIA sodium sulfonate protects against cardiotoxicity induced by doxorubicin in vitro and in vivo.
84  test for significance performed on log
(1 time)
Endocrinology
(1 time)
CBG (1 time)
2017 Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia.
85  test their effect on transthyretin
(1 time)
Biochemistry
(1 time)
EGCG (1 time)
FAP (1 time)
GI (1 time)
2012 Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy.
86  testosterone
(1 time)
Chemistry
(1 time)
17-HPT (1 time)
17beta-HSD (1 time)
ADD (1 time)
2011 Modulation of estrogen synthesis through activation of protein kinase A in H295R cells by extracts of estuary sediments.
87  testosterone rebound
(1 time)
Neoplasms
(1 time)
ADT (1 time)
aHR (1 time)
CVM (1 time)
2018 Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer.
88  testosterone recovery
(1 time)
Neoplasms
(1 time)
HT (1 time)
PCa (1 time)
RT (1 time)
2009 Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.
89  tetraene ratio
(1 time)
Nutritional Sciences
(1 time)
EFAD (1 time)
HTPN (1 time)
1996 Essential fatty acid deficiency and home total parenteral nutrition patients.
90  tetranucleotide tandem repeat
(1 time)
Molecular Biology
(1 time)
--- 2002 [Tetranucleotide tandem repeat polymorphism of the CFTR gene intron 6B in populations of the Volga-Ural region].
91  tetrathionate-reductase activity
(1 time)
Tropical Medicine
(1 time)
--- 1981 [Salmonella typhi lysotypes in Iraq (1974-1979)].
92  Thai Twin Registry
(1 time)
Genetics, Medical
(1 time)
DZ (1 time)
FP (1 time)
MZ (1 time)
2013 Thai Twin Registry: description of the initial stage.
93  than those with transthyretin
(1 time)
Cardiology
(1 time)
--- 2014 Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.
94  than Transthyretin
(1 time)
Biochemistry
(1 time)
FAP (1 time)
2012 Genotype--phenotype correlation in FAP.
95  them, the expression of transthyretin
(1 time)
Neoplasms
(1 time)
AAT (1 time)
CLU (1 time)
CRPC (1 time)
2012 Changes of transthyretin and clusterin after androgen ablation therapy and correlation with prostate cancer malignancy.
96  therapeutic
(1 time)
Geriatrics
(1 time)
INR (1 time)
2011 Quality of management of oral anticoagulation as assessed by time in therapeutic INR range in elderly and younger patients with low mean years of formal education: a prospective cohort study.
97  therapeutic control
(1 time)
Medicine
(1 time)
GSES (1 time)
OAT (1 time)
2017 Effect of a combined education and eHealth programme on the control of oral anticoagulation patients (PORTALS study): a parallel cohort design in Dutch primary care.
98  therapeutic heart rate
(1 time)
Physical Therapy Modalities
(1 time)
DCL (1 time)
DGI (1 time)
EPE (1 time)
2017 Using Xbox kinect motion capture technology to improve clinical rehabilitation outcomes for balance and cardiovascular health in an individual with chronic TBI.
99  therapeutic INR range of 2.0-3.0
(1 time)
Hematology
(1 time)
INR (1 time)
SD (1 time)
2012 Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy.
100  therapeutic range of INR
(1 time)
Vascular Diseases
(1 time)
--- 2013 The influence of VKORC1 and CYP2C9 gene sequence variants on the stability of maintenance phase warfarin treatment.